List of Tables
    Table 1. Nosocomial Infection Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Nosocomial Infection Treatment Market Trends
    Table 3. Nosocomial Infection Treatment Market Drivers
    Table 4. Nosocomial Infection Treatment Market Challenges
    Table 5. Nosocomial Infection Treatment Market Restraints
    Table 6. Global Nosocomial Infection Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Nosocomial Infection Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Nosocomial Infection Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Nosocomial Infection Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Nosocomial Infection Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Nosocomial Infection Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Nosocomial Infection Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Nosocomial Infection Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nosocomial Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nosocomial Infection Treatment as of 2021)
    Table 15. Top Players of Nosocomial Infection Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Nosocomial Infection Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Nosocomial Infection Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Nosocomial Infection Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Nosocomial Infection Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Nosocomial Infection Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Nosocomial Infection Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Nosocomial Infection Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Nosocomial Infection Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Nosocomial Infection Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Nosocomial Infection Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Nosocomial Infection Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Nosocomial Infection Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Nosocomial Infection Treatment Product
    Table 33. Abbott Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. Bayer Company Details
    Table 36. Bayer Business Overview
    Table 37. Bayer Nosocomial Infection Treatment Product
    Table 38. Bayer Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 39. Bayer Recent Development
    Table 40. Becton, Dickinson and Company Company Details
    Table 41. Becton, Dickinson and Company Business Overview
    Table 42. Becton, Dickinson and Company Nosocomial Infection Treatment Product
    Table 43. Becton, Dickinson and Company Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 44. Becton, Dickinson and Company Recent Development
    Table 45. Belimed Company Details
    Table 46. Belimed Business Overview
    Table 47. Belimed Nosocomial Infection Treatment Product
    Table 48. Belimed Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 49. Belimed Recent Development
    Table 50. BioMerieux Company Details
    Table 51. BioMerieux Business Overview
    Table 52. BioMerieux Nosocomial Infection Treatment Product
    Table 53. BioMerieux Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 54. BioMerieux Recent Development
    Table 55. Cantel Company Details
    Table 56. Cantel Business Overview
    Table 57. Cantel Nosocomial Infection Treatment Product
    Table 58. Cantel Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 59. Cantel Recent Development
    Table 60. Cepheid Company Details
    Table 61. Cepheid Business Overview
    Table 62. Cepheid Nosocomial Infection Treatment Product
    Table 63. Cepheid Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 64. Cepheid Recent Development
    Table 65. Getinge Group Company Details
    Table 66. Getinge Group Business Overview
    Table 67. Getinge Group Nosocomial Infection Treatment Product
    Table 68. Getinge Group Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 69. Getinge Group Recent Development
    Table 70. Kimberly-Clark Corp. Company Details
    Table 71. Kimberly-Clark Corp. Business Overview
    Table 72. Kimberly-Clark Corp. Nosocomial Infection Treatment Product
    Table 73. Kimberly-Clark Corp. Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 74. Kimberly-Clark Corp. Recent Development
    Table 75. Merck & Co Company Details
    Table 76. Merck & Co Business Overview
    Table 77. Merck & Co Nosocomial Infection Treatment Product
    Table 78. Merck & Co Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 79. Merck & Co Recent Development
    Table 80. Nordion Company Details
    Table 81. Nordion Business Overview
    Table 82. Nordion Nosocomial Infection Treatment Product
    Table 83. Nordion Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 84. Nordion Recent Development
    Table 85. Pfizer Company Details
    Table 86. Pfizer Business Overview
    Table 87. Pfizer Nosocomial Infection Treatment Product
    Table 88. Pfizer Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 89. Pfizer Recent Development
    Table 90. Roche Company Details
    Table 91. Roche Business Overview
    Table 92. Roche Nosocomial Infection Treatment Product
    Table 93. Roche Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 94. Roche Recent Development
    Table 95. Sakura Seiki Company Details
    Table 96. Sakura Seiki Business Overview
    Table 97. Sakura Seiki Nosocomial Infection Treatment Product
    Table 98. Sakura Seiki Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 99. Sakura Seiki Recent Development
    Table 100. BioMérieux Company Details
    Table 101. BioMérieux Business Overview
    Table 102. BioMérieux Nosocomial Infection Treatment Product
    Table 103. BioMérieux Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 104. BioMérieux Recent Development
    Table 105. Steris Company Details
    Table 106. Steris Business Overview
    Table 107. Steris Nosocomial Infection Treatment Product
    Table 108. Steris Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 109. Steris Recent Development
    Table 110. Johnson & Johnson Company Details
    Table 111. Johnson & Johnson Business Overview
    Table 112. Johnson & Johnson Nosocomial Infection Treatment Product
    Table 113. Johnson & Johnson Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 114. Johnson & Johnson Recent Development
    Table 115. Sterigenics International, Inc. Company Details
    Table 116. Sterigenics International, Inc. Business Overview
    Table 117. Sterigenics International, Inc. Nosocomial Infection Treatment Product
    Table 118. Sterigenics International, Inc. Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 119. Sterigenics International, Inc. Recent Development
    Table 120. Halyard Health, Inc. Company Details
    Table 121. Halyard Health, Inc. Business Overview
    Table 122. Halyard Health, Inc. Nosocomial Infection Treatment Product
    Table 123. Halyard Health, Inc. Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 124. Halyard Health, Inc. Recent Development
    Table 125. Advanced Sterilization Products Company Details
    Table 126. Advanced Sterilization Products Business Overview
    Table 127. Advanced Sterilization Products Nosocomial Infection Treatment Product
    Table 128. Advanced Sterilization Products Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 129. Advanced Sterilization Products Recent Development
    Table 130. Matachana Group Company Details
    Table 131. Matachana Group Business Overview
    Table 132. Matachana Group Nosocomial Infection Treatment Product
    Table 133. Matachana Group Revenue in Nosocomial Infection Treatment Business (2017-2022) & (US$ Million)
    Table 134. Matachana Group Recent Development
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nosocomial Infection Treatment Product Picture
    Figure 2. Global Nosocomial Infection Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Nosocomial Infection Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Nosocomial Infection Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Nosocomial Infection Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Nosocomial Infection Treatment Market Share in Global 2017-2028
    Figure 7. Nosocomial Infection Treatment Report Years Considered
    Figure 8. Product Picture of Antibacterial Treatment
    Figure 9. Product Picture of Antiviral Treatment
    Figure 10. Product Picture of Antifungal Treatment
    Figure 11. Global Nosocomial Infection Treatment Market Share by Type in 2022 & 2028
    Figure 12. Global Nosocomial Infection Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Nosocomial Infection Treatment Market Share by Type (2017-2028)
    Figure 14. United States Nosocomial Infection Treatment Market Share by Type in 2022 & 2028
    Figure 15. United States Nosocomial Infection Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Nosocomial Infection Treatment Market Share by Type (2017-2028)
    Figure 17. Product Picture of Ventilator Associated Pneumonia
    Figure 18. Product Picture of Urinary Tract Infection
    Figure 19. Product Picture of Blood Stream Infection
    Figure 20. Product Picture of Surgical Site Infection
    Figure 21. Product Picture of Gastrointestinal Infection
    Figure 22. Product Picture of MRSA
    Figure 23. Global Nosocomial Infection Treatment Market Share by Application in 2022 & 2028
    Figure 24. Global Nosocomial Infection Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Nosocomial Infection Treatment Market Share by Application (2017-2028)
    Figure 26. United States Nosocomial Infection Treatment Market Share by Application in 2022 & 2028
    Figure 27. United States Nosocomial Infection Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Nosocomial Infection Treatment Market Share by Application (2017-2028)
    Figure 29. North America Nosocomial Infection Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Nosocomial Infection Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Nosocomial Infection Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Nosocomial Infection Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Nosocomial Infection Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Nosocomial Infection Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Abbott Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 58. Bayer Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 59. Becton, Dickinson and Company Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 60. Belimed Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 61. BioMerieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 62. Cantel Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 63. Cepheid Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 64. Getinge Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 65. Kimberly-Clark Corp. Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 66. Merck & Co Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 67. Nordion Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 68. Pfizer Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 69. Roche Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 70. Sakura Seiki Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 71. BioMérieux Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 72. Steris Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 73. Johnson & Johnson Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 74. Sterigenics International, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 75. Halyard Health, Inc. Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 76. Advanced Sterilization Products Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 77. Matachana Group Revenue Growth Rate in Nosocomial Infection Treatment Business (2017-2022)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed